Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study to Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Chinese and Japanese Participants With Ring Sideroblasts Who Require Red Blood Cell Transfusions
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
- Status
- TERMINATED
- Phase
- PHASE1
Haplo Peripheral Blood Sct In GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE1
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE1
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
- Status
- RECRUITING
- Phase
- N/A
Follow-up Study of ICUS and CCUS Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Development and Prospective Validation of a Standardized Flow Cytometric Assay of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- NA
Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
- Status
- WITHDRAWN
- Phase
- NA
Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE3
Sterile Inflammation and Molecular Aberrations in MDS
- Status
- UNKNOWN
- Phase
- N/A
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- N/A
CPX-351 in Higher Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2